ALPS Advisors’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-112,895
| Closed | -$3.22M | – | 1019 |
|
|
2024
Q3 | $3.22M | Sell |
112,895
-1,036
| -0.9% | -$29.5K | 0.02% | 284 |
|
|
2024
Q2 | $3.01M | Buy |
+113,931
| New | +$3.01M | 0.02% | 286 |
|
|
2023
Q4 | – | Sell |
-96,434
| Closed | -$3.7M | – | 987 |
|
|
2023
Q3 | $3.7M | Buy |
96,434
+578
| +0.6% | +$22.2K | 0.03% | 239 |
|
|
2023
Q2 | $1.82M | Buy |
95,856
+10,043
| +12% | +$191K | 0.02% | 329 |
|
|
2023
Q1 | $1.33M | Sell |
85,813
-1,755
| -2% | -$27.2K | 0.01% | 385 |
|
|
2022
Q4 | $1.55M | Buy |
87,568
+23,896
| +38% | +$424K | 0.01% | 348 |
|
|
2022
Q3 | $355K | Sell |
63,672
-5,438
| -8% | -$30.3K | ﹤0.01% | 672 |
|
|
2022
Q2 | $270K | Sell |
69,110
-50,515
| -42% | -$197K | ﹤0.01% | 899 |
|
|
2022
Q1 | $659K | Sell |
119,625
-13,467
| -10% | -$74.2K | 0.01% | 381 |
|
|
2021
Q4 | $1.13M | Sell |
133,092
-7,860
| -6% | -$67K | 0.01% | 345 |
|
|
2021
Q3 | $1.23M | Buy |
140,952
+11,904
| +9% | +$103K | 0.01% | 367 |
|
|
2021
Q2 | $1.36M | Sell |
129,048
-48,198
| -27% | -$509K | 0.01% | 371 |
|
|
2021
Q1 | $2.84M | Buy |
177,246
+19,846
| +13% | +$318K | 0.03% | 223 |
|
|
2020
Q4 | $7.27M | Buy |
+157,400
| New | +$7.27M | 0.08% | 156 |
|